Clinical Trial

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Name: Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer — clinical trial record (NCT07316439)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study aimed to compare survival outcomes and clinical characteristics between ER loss and metastatic triple-negative breast cancer (mTNBC) patients, exploring the prognostic implications of dynamic ER changes.

Trial Details

NCT Number	NCT07316439
Lead Sponsor	Fudan University
Conditions	Breast Cancer
Enrollment	197 participants
Start Date	2024-12-31
Primary Completion	2025-06-05 (estimated)
Study Completion	2026-06-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-05